《半日總結》恆指跌612點 科網及內房股受壓 新東方系彈
美國上月通脹超市場預期,港股早市隨外圍下跌。恆指低開643點,跌幅曾收窄至486點一度低見21,320點,半日跌612或2.81%,報21,193點;國指跌216點或2.84%,報7,392點;恆生科技指數跌176點或3.66%,報4,649點。大市半日成交總額933.32億元,滬、深港通南下交易半日分別淨流入23.99億及19.48億元人民幣。
科技股方面,阿里巴巴(09988.HK)跌5.9%報106.1元,騰訊(00700.HK)跌4.6%報378.2元,美團(03690.HK)跌4.2%報192.7元,小米(01810.HK)跌3.6%報11.74元,京東(09618.HK)跌2.7%報244元。百度(09888.HK)及嗶哩嗶哩(09626.HK)各跌6.7%及7.2%,網易(09999.HK)跌4.8%。京東健康(06618.HK)、明源雲(00909.HK)及萬國數據(09698.HK)各跌7.3%至8.2%。
報道指新東方「雙語帶貨」火熱,單日銷售額逾千萬人幣,新東方(09901.HK)炒高12%,新東方在線(01797.HK)暴漲74%。
手機部件股舜宇(02382.HK)及瑞聲(02018.HK)各跌3%。汽車股小鵬(09868.HK)及蔚來(09866.HK)各跌4.3%及5.4%。內需股隨大市下跌,JS環球生活(01691.HK)跌7.3%,九毛九(09922.HK)及百勝中國(09987.HK)各跌5.9%及5.5%,海底撈(06862.HK)及頤海(01579.HK)各跌4.1%及4.5%。醫藥股藥明康德(02359.HK)擬議股東計劃減持最多8,868萬A股,H股股價挫10.3%,同系藥明生物(02269.HK)挫4.8%。
碧桂園(02007.HK)及物管股碧服(06098.HK)各跌8.4%及7.8%,合景泰富(01813.HK)挫9.9%,旭輝(00884.HK)、龍湖(00960.HK)、富力(02777.HK)及雅居樂(03383.HK)各跌4.3%至4.8%。
油價回落,中海油(00883.HK)跌2.8%。航運股中遠海能(01138.HK)及東方海外(00316.HK)各跌3.7%及5%。金融股方面,匯控(00005.HK)跌2.1%報48.9元,港交所(00388.HK)跌2.6%報345.8元,友邦(01299.HK)跌2.7%報78.75元。內銀股招行(03968.HK)跌3.8%,
藍籌新貴中國宏橋(01378.HK)跌5.9%,中芯(00981.HK)平收報18.86元,中升(00881.HK)跌2.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.